CLINICAL THYROIDOLOGY FOR PATIENTS
A publication of the American Thyroid Association
Table of Contents
Welcome to Clinical Thyroidology for Patients and Happy New Year! I realize that I am a month late; however this month’s edition is playing catch-up by giving you a double issue. With this issue, we will be on a schedule that will allow us to follow the physician-oriented Clinical Thyroidology publication within 2–3 weeks. This means that you, the patients, will be getting the latest information on thyroid research and treatment almost as soon as your physicians. We will continue to summarize the top articles from the recent medical literature that cover the broad spectrum of thyroid disorders.
The Calendar of Events highlights educational forums and support groups that are organized by members of the Alliance for Thyroid Patient Education. The Alliance member groups consist of: the American Thyroid Association, the Graves’ Disease Foundation, the Light of Life Foundation and ThyCa: Thyroid Cancer Survivors Association. In this issue, we are highlighting the Graves’ Disease Foundation as they report on the success of their annual meeting.
IN THIS ISSUE, STUDIES ASK THE FOLLOWING QUESTIONS:
- Is the new drug Motesanib effective in patients with medullary thyroid cancer?
- What is the link between the thyroid and heart disease?
- What are the risks of thyroid surgery in patients over the age of 80 years?
- What is the best way to prepare low risk thyroid cancer patients for RAI therapy?
- What is the best surgery for patients with familial medullary thyroid cancer?
- What are the features of papillary thyroid cancer that arises in a thyroglossal duct cyst?
- Does Lithium treatment increase the success rate of RAI in patients with Graves’ disease?
- What is the response of children with Graves’ disease to RAI treatment?
- Is the new NCI classification system helpful in interpreting thyroid biopsy results?
- Should elderly patients with thyroid cancer be treated differently than younger patients?
We welcome your feedback and suggestions. Please follow this link to let us know what you want to see in this publication. I hope you find these summaries interesting and informative.
— Alan Farwell, MD